Amílcar Celta Falcão Ramos Ferreira
AuthID: R-000-0HR
211
TITLE: Steady-state pharmacokinetics of once-daily and twice-daily regimens of eslicarbazepine acetate (BIA 2-093) in healthy subjects
AUTHORS: Luis Almeida; Amilcar Falcao; Joana Maia; Manuel Vaz da Silva; Patricio Soares da Silva ;
PUBLISHED: 2006, SOURCE: 60th Annual Meeting of the American-Epilepsy-Society in EPILEPSIA, VOLUME: 47
AUTHORS: Luis Almeida; Amilcar Falcao; Joana Maia; Manuel Vaz da Silva; Patricio Soares da Silva ;
PUBLISHED: 2006, SOURCE: 60th Annual Meeting of the American-Epilepsy-Society in EPILEPSIA, VOLUME: 47
INDEXED IN: 
WOS
WOS212
TITLE: Effect of single-doses of nebicapone (BIA 3-202) on the catechol-O-methyltransferase (COMT) activity in healthy subjects
AUTHORS: Almeida, L; Falcao, A; Vaz da Silva, M; Wright, L; Torrao, L; Igreja, B; Soares, E; Maia, J; Nunes, T; Soares da Silva, P ;
PUBLISHED: 2006, SOURCE: 10th International Congress of Parkinson's Disease and Movement Disorders in MOVEMENT DISORDERS, VOLUME: 21
AUTHORS: Almeida, L; Falcao, A; Vaz da Silva, M; Wright, L; Torrao, L; Igreja, B; Soares, E; Maia, J; Nunes, T; Soares da Silva, P ;
PUBLISHED: 2006, SOURCE: 10th International Congress of Parkinson's Disease and Movement Disorders in MOVEMENT DISORDERS, VOLUME: 21
INDEXED IN: WOS
WOS213
TITLE: Eslicarbazepine acetate (BIA 2-093): Relative bioavailability and bioequivalence of 50 mg/mL oral suspension and 200 mg and 800 mg tablet formulations
AUTHORS: Nunes, T; Falcao, A; Almeida, L; Lima, R; Tavares, S; Neta, C; Fontes Ribeiro, C; Macedo, T; Soares da Silva, P ;
PUBLISHED: 2005, SOURCE: 26th International Epilepsy Congress in EPILEPSIA, VOLUME: 46
AUTHORS: Nunes, T; Falcao, A; Almeida, L; Lima, R; Tavares, S; Neta, C; Fontes Ribeiro, C; Macedo, T; Soares da Silva, P ;
PUBLISHED: 2005, SOURCE: 26th International Epilepsy Congress in EPILEPSIA, VOLUME: 46
INDEXED IN: WOS
WOS214
TITLE: Relative bioavailability and bioequivalence of three different oral formulations of eslicarbazepine acetate
AUTHORS: Nunes, T; Falcao, A; Almeida, L; Lima, R; Tavares, S; Neta, C; Fontes Ribeiro, C; Macedo, T; Soares da Silva, P ;
PUBLISHED: 2005, SOURCE: Joint Annual Meeting of the American-Epilepsy-Society/American-Clinical-Neurophsiology-Society in EPILEPSIA, VOLUME: 46
AUTHORS: Nunes, T; Falcao, A; Almeida, L; Lima, R; Tavares, S; Neta, C; Fontes Ribeiro, C; Macedo, T; Soares da Silva, P ;
PUBLISHED: 2005, SOURCE: Joint Annual Meeting of the American-Epilepsy-Society/American-Clinical-Neurophsiology-Society in EPILEPSIA, VOLUME: 46
INDEXED IN: WOS
WOS215
TITLE: Effect of age and gender on the pharmacokinetics of eslicarbazepine acetate
AUTHORS: Soares Da Silva, P ; Almeida, L; Falcao, A; Maia, J;
PUBLISHED: 2005, SOURCE: Joint Annual Meeting of the American-Epilepsy-Society/American-Clinical-Neurophsiology-Society in EPILEPSIA, VOLUME: 46
AUTHORS: Soares Da Silva, P ; Almeida, L; Falcao, A; Maia, J;
PUBLISHED: 2005, SOURCE: Joint Annual Meeting of the American-Epilepsy-Society/American-Clinical-Neurophsiology-Society in EPILEPSIA, VOLUME: 46
INDEXED IN: WOS
WOS216
TITLE: Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2-093), a new voltage-gated sodium channel inhibitor
AUTHORS: Almeida, L; Falcao, A; Maia, J; Mazur, D; Gellert, M; da Silva, PS;
PUBLISHED: 2005, SOURCE: 26th International Epilepsy Congress in EPILEPSIA, VOLUME: 46
AUTHORS: Almeida, L; Falcao, A; Maia, J; Mazur, D; Gellert, M; da Silva, PS;
PUBLISHED: 2005, SOURCE: 26th International Epilepsy Congress in EPILEPSIA, VOLUME: 46
INDEXED IN: WOS
WOS217
TITLE: Effect of food on the pharmacokinetic profile of eslicarbazepine acetate (BIA 2-093) Full Text
AUTHORS: Maia, J; Vaz Da Silva, M ; Almeida, L; Falcao, A; Silveira, P; Guimaraes, S; Graziela, P; Soares Da Silva, P ;
PUBLISHED: 2005, SOURCE: Drugs in R and D, VOLUME: 6, ISSUE: 4
AUTHORS: Maia, J; Vaz Da Silva, M ; Almeida, L; Falcao, A; Silveira, P; Guimaraes, S; Graziela, P; Soares Da Silva, P ;
PUBLISHED: 2005, SOURCE: Drugs in R and D, VOLUME: 6, ISSUE: 4
218
TITLE: Eslicarbazepine Acetate (BIA 2-093). Relative Bioavailability and Bioequivalence of 50 mg/mL Oral Suspension and 200mg and 800mg Tablet Formulations Full Text
AUTHORS: Carlos Fontes-Ribeiro; Teresa Nunes; Amilcar Falc??o; Carla Neta; Ricardo Lima; Susana Tavares; Luis Almeida; Tice Macedo; Patricio Soares-da-Silva ;
PUBLISHED: 2005, SOURCE: Drugs in R & D, VOLUME: 6, ISSUE: 5
AUTHORS: Carlos Fontes-Ribeiro; Teresa Nunes; Amilcar Falc??o; Carla Neta; Ricardo Lima; Susana Tavares; Luis Almeida; Tice Macedo; Patricio Soares-da-Silva ;
PUBLISHED: 2005, SOURCE: Drugs in R & D, VOLUME: 6, ISSUE: 5
219
TITLE: Lamotrigine pharmacokinetic/pharmacodynamic modelling Full Text
AUTHORS: Castel Branco, MM; Lebre, VL; Alves, GL; Figueiredo, IV; Falcao, AC; Caramona, MM;
PUBLISHED: 2004, SOURCE: FUNDAMENTAL & CLINICAL PHARMACOLOGY, VOLUME: 18
AUTHORS: Castel Branco, MM; Lebre, VL; Alves, GL; Figueiredo, IV; Falcao, AC; Caramona, MM;
PUBLISHED: 2004, SOURCE: FUNDAMENTAL & CLINICAL PHARMACOLOGY, VOLUME: 18
INDEXED IN: WOS
WOS220
TITLE: Assessment of the relationship between lamotrigine plasma and brain profiles and its anticonvulsant effect in rats Full Text
AUTHORS: Lebre, VL; Castel Branco, MM; Alves, GL; Figueiredo, IV; Falcao, AC; Caramona, MM;
PUBLISHED: 2004, SOURCE: FUNDAMENTAL & CLINICAL PHARMACOLOGY, VOLUME: 18
AUTHORS: Lebre, VL; Castel Branco, MM; Alves, GL; Figueiredo, IV; Falcao, AC; Caramona, MM;
PUBLISHED: 2004, SOURCE: FUNDAMENTAL & CLINICAL PHARMACOLOGY, VOLUME: 18
INDEXED IN: WOS
WOS